← SynDRA
GSK2879552
SynDRA canonical compound SYN0038549 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | KDM1A |
|---|
| Mechanism of action | histone lysine demethylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- histone lysine demethylase inhibitor
Cross-references
Synonyms
- Gsk-2879552
- GT77Z6Y09Z
- CHEBI:176334
- RefChem:144555
- MFCD28411435
- UNII-GT77Z6Y09Z
- Example 26 [WO2012135113]
- GTPL9116
- orb1693457
- GSK2879552 HCl
- SCHEMBL12813936
- GSK-2879552 HCl
- Gsk2879522
- LRULVYSBRWUVGR-FCHUYYIVSA-N
- GLXC-90330
- EX-A1181
- BDBM50158869
- NSC783917
- AKOS027324406
- CS-3997
- GSK 2879552 [WHO-DD]
- NSC-783917
- NCGC00387878-01
- NCGC00387878-03
- AC-35762
- AS-56180
- BG170574
- DA-73911
- HY-18632
- BRD-K09223495-001-01-4
- GSK2879552; GSK-2879552; GSK 2879552
- GSK-2879552
- T4418
- AKOS032945153
- GSK2879552 2HCl (1401966-69-5(free base))
- orb1302876
- SCHEMBL17673946
- GSK2879552 (dihydrochloride)
Look up GSK2879552 in the interactive SynDRA portal →